Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

POSB369 development of the patient-reported impact of dermatological diseases (PRIDD) measure

Pattinson, R. ORCID:, Trialonis-Suthakharan, N., Austin, J., Augustin, M. and Bundy, C. ORCID: 2022. POSB369 development of the patient-reported impact of dermatological diseases (PRIDD) measure. Value in Health 25 (1) , S232. 10.1016/j.jval.2021.11.1136

[thumbnail of POSB369 Development of the Patient-Reported Impact of Dermatological Diseases (PRIDD) Measure ACCEPTED POSTPRINT.pdf] PDF - Accepted Post-Print Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (113kB)


Dermatological conditions are the fourth most common health condition worldwide and carry a physical, psychological and social burden for patients. The existing burden metrics in dermatology (e.g. patient-reported outcome measures [PROMs]) arguably underestimate the breadth of the impact of dermatological conditions on patients’ lives. The Global Research on the Impact of Dermatological Diseases (GRIDD) project is developing a new measure (Patient-Reported Impact of Dermatological Diseases - PRIDD) to better understand the true impact. GRIDD is the first global patient-initiated and -led impact research study in dermatology.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Healthcare Sciences
Publisher: Elsevier
ISSN: 1098-3015
Date of First Compliant Deposit: 21 April 2022
Date of Acceptance: 19 August 2021
Last Modified: 08 Nov 2023 08:25

Actions (repository staff only)

Edit Item Edit Item


Downloads per month over past year

View more statistics